search
Back to results

The Success Rate of Cryotherapy Application in Primary Molars With Signs of Irreversible Pulpitis

Primary Purpose

Pain, Procedural

Status
Recruiting
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Cryotherapy
Traditional local anesthesia
Sponsored by
Minia University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Pain, Procedural

Eligibility Criteria

5 Years - 9 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy children are classified as I or II according to ASA
  • Presence of at least one mandibular primary molar with symptomatic signs of irreversible pulpitis
  • Presence of at least two-thirds of the root length in periapical radiograph

Exclusion Criteria:

  • Unrestorable crowns
  • Children with systemic, severe behavior or emotional problems
  • Presence of gingival redness, swellings, fistulous of sinus tract
  • Radiographic evidence of internal root resorption, pulp stones or calcifications, and/or bone radiolucency

Sites / Locations

  • Omar AhmedRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Cryotherapy during inferior alveolar nerve block

Inferior alveolar nerve block

Arm Description

Outcomes

Primary Outcome Measures

Pain assessment
Wong Backer pain scale

Secondary Outcome Measures

Full Information

First Posted
February 22, 2022
Last Updated
March 2, 2022
Sponsor
Minia University
search

1. Study Identification

Unique Protocol Identification Number
NCT05267847
Brief Title
The Success Rate of Cryotherapy Application in Primary Molars With Signs of Irreversible Pulpitis
Official Title
The Success Rate of Cryotherapy Application in Primary Molars With Signs of Irreversible
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
February 22, 2022 (Anticipated)
Primary Completion Date
April 30, 2022 (Anticipated)
Study Completion Date
April 30, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Minia University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The study is designed as a randomized controlled trial with two parallel groups. Children aged 5-9 years with primary molars from suffered symptomatic signs of irreversible pulpitis will be randomly assigned into two groups. The first group (experimental group) will be injected with 4% articaine 1:100.000 epinephrine (inferior alveolar nerve block). For the second group, the mandibular second primary molars will be anesthetized using 4% articaine 1:100.000 epinephrine using inferior alveolar nerve block.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Procedural

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
188 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cryotherapy during inferior alveolar nerve block
Arm Type
Experimental
Arm Title
Inferior alveolar nerve block
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
Cryotherapy
Intervention Description
local anesthetic injection with articaine 4% 1:100,000 epinephrine then an application ice packs
Intervention Type
Other
Intervention Name(s)
Traditional local anesthesia
Intervention Description
local anesthetic injection with articaine 4% 1:100,000 epinephrine
Primary Outcome Measure Information:
Title
Pain assessment
Description
Wong Backer pain scale
Time Frame
up to 24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
9 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy children are classified as I or II according to ASA Presence of at least one mandibular primary molar with symptomatic signs of irreversible pulpitis Presence of at least two-thirds of the root length in periapical radiograph Exclusion Criteria: Unrestorable crowns Children with systemic, severe behavior or emotional problems Presence of gingival redness, swellings, fistulous of sinus tract Radiographic evidence of internal root resorption, pulp stones or calcifications, and/or bone radiolucency
Facility Information:
Facility Name
Omar Ahmed
City
Al Minyā
ZIP/Postal Code
61111
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Omar Ahmed, PhD
Phone
0020862347768
Email
EG135.30708112400351@nies-edu.org

12. IPD Sharing Statement

Learn more about this trial

The Success Rate of Cryotherapy Application in Primary Molars With Signs of Irreversible Pulpitis

We'll reach out to this number within 24 hrs